Sandimmun 50 mg Injection 1 ml

Sandimmun 50 mg Injection 1 ml belongs to the class of medicines called immunosuppressants, used to prevent organ rejection after a transplant. It may also be indicated in autoimmune conditions like psoriasis and rheumatoid arthritis.

Sandimmun 50 mg Injection 1 ml contains cyclosporine, which works by suppressing the immune response. Thereby, it helps to prevent organ rejection.

Sandimmun 50 mg Injection 1 ml may cause side effects like nausea, vomiting, headache, and abdominal pain. Talk to your doctor if any of the side effects persist or worsen.

Let your doctor know about your medical condition and the medications you are taking to avoid potential interactions. Inform your doctor if you are pregnant or breastfeeding.

Sandimmun 50 mg Injection 1 ml is primarily used to prevent transplant rejection. The detailed uses of Sandimmun 50 mg Injection 1 ml are as follows:

• Prevention of organ rejection: Sandimmun 50 mg Injection 1 ml prevents graft rejection after transplants, such as kidney, liver, and heart transplants.
• Manage graft-versus-host disease (GVHD): Used after bone marrow or stem cell transplants to prevent and treat GVHD, a condition where donor cells attack the recipient's tissues.
• Autoimmune conditions: Treat autoimmune diseases such as rheumatoid arthritis, psoriasis, lupus, and nephrotic syndrome.

• Follow your doctor's instructions on the dosage and timing of this medication.
• Sandimmun 50 mg Injection 1 ml will be administered by a doctor or nurse in a healthcare facility.
• Do not self-administer.

• Sandimmun 50 mg Injection 1 ml helps prevent graft rejection in patients undergoing solid organ transplants, such as kidney, liver, heart, and lung transplants.
• It promotes long-term survival and function of the transplanted organ by suppressing the immune system.
• It is used to manage and reverse cellular rejection episodes in transplant recipients who were previously on other immunosuppressive therapies.
• Sandimmun 50 mg Injection 1 ml prevents graft rejection in patients receiving allogeneic bone marrow or stem cell transplants.
• It plays a critical role in preventing and treating graft-versus-host disease (GVHD), a serious complication where donor immune cells attack the recipient’s body.
• Cyclosporine works by selectively inhibiting the activation of T-lymphocytes, key players in the immune response, thereby reducing the risk of tissue rejection.
• It ensures a more stable post-transplant period and improves overall transplant success rates.

• Do not receive Sandimmun 50 mg Injection 1 ml if you are allergic to any of its components.
• Inform your doctor if you have liver or kidney problems, high blood pressure, high lipid levels, low magnesium levels, high potassium levels, high uric acid levels or if you are due to undergo vaccinations.
• If you are pregnant or breastfeeding, inform your doctor before receiving Sandimmun 50 mg Injection 1 ml.
• Sandimmun 50 mg Injection 1 ml may cause sleepiness, disorientation, or blurred vision. Drive and operate machinery only if you are alert.
• Let your doctor know about all your medical conditions, sensitivities, and all medications (including herbal and supplement products) you are using.